CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-05-20 | ORBIMED ADVISORS LLC Director | Purchase | +2,400 | $10.04 | $24K | 28,043,404 |
| 2016-05-19 | Sigal Charles Elliott Director | Purchase | +15,000 | $1.56 | $23K | 314,100 |
| 2016-05-18 | Sigal Charles Elliott Director | Purchase | +15,000 | $1.55 | $23K | 299,100 |
| 2016-05-17 | Sigal Charles Elliott Director | Purchase | +15,000 | $1.53 | $23K | 284,100 |
| 2016-05-16 | Sigal Charles Elliott Director | Purchase | +15,000 | $1.50 | $23K | 269,100 |
| 2016-01-18 | Rawcliffe Adrian Chief Financial Officer | Grant or award · Option to purchase Ordinary Shares | +939,948 | 939,948 | ||
| 2016-01-18 | Binder-Scholl Gwendolyn Knowlton EVP, Adaptimmune LLC | Grant or award · Option to purchase Ordinary Shares | +704,961 | 704,961 | ||
| 2016-01-18 | TAYTON-MARTIN HELEN KATRINA Chief Operating Officer | Grant or award · Option to purchase Ordinary Shares | +939,948 | 939,948 | ||
| 2016-01-18 | Noble James Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +1,968,016 | 1,968,016 | ||
| 2016-01-18 | Amado Rafael Chief Medical Officer | Grant or award · Option to purchase Ordinary Shares | +939,948 | 939,948 |
Page 24 of 24 · 470 trades